Shandong Intco Medical Products Co Ltd (300677) — Tangible Net Worth Ratio
Shandong Intco Medical Products Co Ltd (300677) has a Tangible Net Worth Ratio of 96.0% as of September 2025. This metric is calculated by deducting intangible assets (CN¥732.72 Million) from net assets (CN¥18.47 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Shandong Intco Medical Products Co Ltd net assets for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Shandong Intco Medical Products Co Ltd Tangible Net Worth Ratio (2013–2024)
This chart shows how Shandong Intco Medical Products Co Ltd's Tangible Net Worth Ratio has changed across 12 annual periods from 2013 to 2024. As of September 2025, the ratio stands at 96.0%, reflecting net assets of CN¥18.47 Billion with intangible assets of CN¥732.72 Million CNY. Also explore 300677 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Shandong Intco Medical Products Co Ltd (2013–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Shandong Intco Medical Products Co Ltd from 2013 to 2024, covering 12 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see 300677 market cap overview.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 95.7% | CN¥17.68 Billion | CN¥767.03 Million | CN¥34.63 Billion | ▼ -0.9 pp |
| 2023 | 96.5% | CN¥16.29 Billion | CN¥566.84 Million | CN¥27.08 Billion | ▲ +0.2 pp |
| 2022 | 96.4% | CN¥16.05 Billion | CN¥583.48 Million | CN¥21.48 Billion | ▲ +0.3 pp |
| 2021 | 96.1% | CN¥16.12 Billion | CN¥629.91 Million | CN¥20.62 Billion | ▼ -0.2 pp |
| 2020 | 96.3% | CN¥9.44 Billion | CN¥349.48 Million | CN¥12.93 Billion | ▲ +9.3 pp |
| 2019 | 87.0% | CN¥1.50 Billion | CN¥195.34 Million | CN¥2.99 Billion | ▼ -5.8 pp |
| 2018 | 92.8% | CN¥1.27 Billion | CN¥91.60 Million | CN¥2.42 Billion | ▼ -4.2 pp |
| 2017 | 97.1% | CN¥1.09 Billion | CN¥32.05 Million | CN¥1.66 Billion | ▲ +1.2 pp |
| 2016 | 95.9% | CN¥502.40 Million | CN¥20.78 Million | CN¥1.09 Billion | ▲ +1.0 pp |
| 2015 | 94.9% | CN¥415.19 Million | CN¥21.32 Million | CN¥754.13 Million | ▲ +6.1 pp |
| 2014 | 88.7% | CN¥168.38 Million | CN¥18.99 Million | CN¥656.54 Million | ▼ -0.5 pp |
| 2013 | 89.2% | CN¥147.82 Million | CN¥16.00 Million | CN¥704.49 Million | — |